Search Results - "NORTILLI, R"

A propensity score analysis exploring the impact of the addition of adjuvant chemotherapy (aCT) to hormone therapy (aHT) in a multi-center series of resected luminal early stage pure invasive lobular breast carcinoma (ILC) by Carbognin, L., Sperduti, I., Arpino, G., Dieci, M.V., Schettini, F., Griguolo, G., Brunelli, M., Guarneri, V., Nortilli, R., Fiorio, E., Pilotto, S., Orvieto, E., Manfrin, E., Conte, P., de Placido, S., Scambia, G., Tortora, G., Bria, E.

Get full text

A propensity score analysis exploring the impact of adjuvant chemotherapy (aCT) in 739 patients (pts) affected by early stage pure Invasive Lobular breast Carcinoma (ILC) by Carbognin, L, Sperduti, I, Arpino, G, Dieci, M V, Schettini, F, Guarneri, V, Griguolo, G, Nortilli, R, Fiorio, E, Parolin, V, Pilotto, S, Brunelli, M, Manfrin, E, Orvieto, E, Pellini, F, Pollini, G P, Conte, P, De Placido, S, Tortora, G, Bria, E

Get full text

Renal toxicity and osteonecrosis of the jaw in cancer patients treated with bisphosphonates: a long-term retrospective analysis by Bonomi, M., Nortilli, R., Molino, A., Sava, T., Santo, A., Caldara, A., Cetto, G. L.

“…Background : Bisphosphonates (BPs) are the mainstay of bone-directed therapy for bone metastases from multiple myelomas and a wide range of solid tumours, but…”
Get full text

Quality of life evaluation in a randomised trial of chemotherapy versus bio-chemotherapy in advanced melanoma patients by Chiarion-Sileni, V., Del Bianco, P., De Salvo, G.L., Re, G.Lo, Romanini, A., Labianca, R., Nortilli, R., Corgna, E., Palma, M.Dalla, Presti, G.Lo, Ridolfi, R.

“…This study analyses the health related quality of life (HRQOL) of advanced melanoma patients, in a randomised trial comparing bio-chemotherapy (bio-CT) versus…”
Get full text

Carboplatin, doxorubicin and etoposide in the treatment of tumours of unknown primary site by PIGA, A, NORTILLI, R, MONTIRONI, R, GESUITA, R, CARLE, F, CELLERINO, R, CETTO, G. L, CARDARELLI, N, FEDELI, S. Luzi, FIORENTINI, G, D'APRILE, M, GIORGI, F, PARZIALE, A. P, CONTU, A

“…The aim of this study was to assess the activity and toxicity of a platinum-based treatment on a group of patients with unknown primary tumours (UPTs)…”
Get full text

Phase II randomized study of dacarbazine, carmustine, cisplatin and tamoxifen versus dacarbazine alone in advanced melanoma patients by Chiarion Sileni, V, Nortilli, R, Aversa, S M, Paccagnella, A, Medici, M, Corti, L, Favaretto, A G, Cetto, G L, Monfardini, S

“…This randomized phase II trial was performed to define the activity and toxicity of the combination of dacarbazine (DTIC), carmustine (BCNU), cisplatin (DDP)…”
Get full text

7019 POSTER Long-term outcome of patients with advanced melanoma by Parolin, V, Nortilli, R, Strina, C, Sabbioni, R, Sava, T, Cetto, G.L

Get full text

Comparative study of clinical, pathological and biological characteristics of symptomatic versus asymptomatic breast cancers by Molino, A., Pavarana, M., Micciolo, R., Nortilli, R., Pedersini, R., Manno, P., Bozzi, P., Bonetti, F., Piubello, Q., Cetto, L. G.

“…Background: It is well known that mammographic screening reduces breast cancer mortality. One possible explanation for this effect is that screening makes it…”
Get full text

Prognostic significance of estrogen receptors in 405 primary breast cancers : a comparison of immunohistochemical and biochemical methods by MOLINO, A, MICCIOLO, R, BONETTI, A, NORTILLI, R, TOMEZZOLI, A, POLLINI, G. P, MODENA, S, CETTO, G. L, TURAZZA, M, BONETTI, F, PIUBELLO, Q, CORGNATI, A, SPEROTTO, L, RECALDIN, E, SPAGNOLLI, P, MANFRIN, E

“…Over the last few years, estrogen receptor determination by means of immunohistochemistry has been extensively used. The aim of this study was to compare this…”
Get full text

A double blind randomized study of oral clodronate in the treatment of bone metastases from tumors poorly responsive to chemotherapy by Piga, A, Bracci, R, Ferretti, B, Sandri, P, Nortilli, R, Acito, L, Pancotti, A, Di Furia, L, Carle, F, Cellerino, R

“…Bisphosphonates are used in oncology as a means of decreasing complications due to bone metastases, in association with anticancer treatment, especially in…”
Get more information

197PA propensity score analysis exploring the impact of the addition of adjuvant chemotherapy (aCT) to hormone therapy (aHT) in a multi-center series of resected luminal early stage pure invasive lobular breast carcinoma (ILC) by Carbognin, L, Sperduti, I, Arpino, G, Dieci, M V, Schettini, F, Griguolo, G, Brunelli, M, Guarneri, V, Nortilli, R, Fiorio, E, Pilotto, S, Orvieto, E, Manfrin, E, Conte, P, de Placido, S, Scambia, G, Tortora, G, Bria, E

Get full text

ESR1, Ph-mTOR, CDK4/6 and PD-L1 expression as prognostic (and potentially druggable) drivers for pure invasive lobular breast carcinoma (ILC): Preliminary results of prognostic outliers according to a clinical-pathological model by Carbognin, L., Brunelli, M., Manfrin, E., Caliò, A., Sperduti, I., Dieci, M.V., Griguolo, G., Guarneri, V., Nortilli, R., Pilotto, S., Fiorio, E., Parolin, V., Orvieto, E., Pellini, F., Pollini, G.P., Conte, P.F., Scarpa, A., Tortora, G., Bria, E.

Get full text

Development of a risk model to identity prognostic ‘outliers’ underwent surgery for early-stage invasive lobular breast carcinoma (ILBC) according to clinical and pathological factors by Carbognin, L., Sperduti, I., Furlanetto, J., Vicentini, C., Nortilli, R., Brunelli, M., Manfrin, E., Nottegar, A., Pellini, F., Pollini, G.P., Bonetti, F., Bria, E., Tortora, G.

Get full text

Prognostic impact of Ki67 for resected early stage pure Invasive Lobular breast Cancer (ILC): cut-off analysis and clinical validation by Carbognin, L., Sperduti, I., Fabi, A., Dieci, M.V., Zampiva, I., Griguolo, G., Pilotto, S., Guarneri, V., Brunelli, M., Nortilli, R., Manfrin, E., Fiorio, E., Parolin, V., Filippi, E., Pellini, F., Pollini, G.P., Nisticò, C., Conte, P., Tortora, G., Bria, E.

Get full text

Estrogen receptors in 699 primary breast cancers : a comparison of immunohistochemical and biochemical methods by MOLINO, A, MICCIOLO, R, CASTELLI, P, RODELLA, S, CAPELLI, P, MANFRIN, E, PELOSI, G, CETTO, G. L, TURAZZA, M, BONETTI, F, PIUBELLO, Q, CORGNATI, A, SPEROTTO, L, MARTIGNONI, G, BONETTI, A, NORTILLI, R

“…Over the last few years, estrogen receptor (ER) determination by immunohistochemistry (ER-ICA) has been extensively used, but it still remains to be…”
Get full text

Clinical and pathological predictors of Advanced Breast Carcinoma with Luminal subtype (ABC-Lum) identifying prognostic ‘outliers’: multicenter retrospective analysis in the ‘real-world’ scenario by Sperduti, I., Carbognin, L., Ciccarese, M., Fabi, A., Petrucelli, L., Vari, S., Forcignanò, R.C., Furlanetto, J., Vicentini, C., Nortilli, R., Brunelli, M., Nottegar, A., Giannarelli, D., Tortora, G., Bria, E.

Get full text

Prognostic impact of proliferation for resected early stage breast cancer according to histology: Cut-off analysis of Ki67 in 859 patients with pure invasive lobular and ductal breast carcinoma (ILC/IDC) by Carbognin, L., Sperduti, I., Dieci, M.V., Zampiva, I., Griguolo, G., Pilotto, S., Guarneri, V., Brunelli, M., Nortilli, R., Manfrin, E., Fiorio, E., Parolin, V., Filippi, E., Pellini, F., Bonetti, F., Pollini, G.P., Conte, P.F., Tortora, G., Bria, E.

Get full text

Cisplatin, Dacarbazine With or Without Subcutaneous Interleukin-2, and Interferon Alfa-2b in Advanced Melanoma Outpatients: Results From an Italian Multicenter Phase III Randomized Clinical Trial by Ridolfi, R.

Get full text

Ki‐67 immunostaining in 322 primary breast cancers: Associations with clinical and pathological variables and prognosis by Molino, Annamaria, Micciolo, Rocco, Turazza, Monica, Bonetti, Franco, Piubello, Quirino, Bonetti, Andrea, Nortilli, Rolando, Pelosi, Giuseppe, Cetto, Gian Luigi

“…Cell‐proliferation markers are very important in the clinical management of cancer patients, and the identification of Ki‐67 (a monoclonal antibody that…”
Get full text

Platinum and etoposide as second-line chemotherapy in advanced adult soft tissue sarcomas by Pavarana, M., Fraccon, A., Sava, T., Manno, P., Nortilli, R., Sabbioni, R., Valcamonico, F., Frisinghelli, M., Zaninelli, M., Cetto, G.

“…Abstract only…”
Get full text